File(s) under permanent embargo
ATF3 repression of BCL-XL determines apoptotic sensitivity to HDAC inhibitors across tumor types
journal contribution
posted on 2017-09-01, 00:00 authored by A C Chüeh, J W T Tse, M Dickinson, P Ioannidis, L Jenkins, L Togel, B S Tan, I Luk, M Davalos-Salas, R Nightingale, M R Thompson, B R G Williams, G Lessene, E F Lee, W D Fairlie, Amardeep DhillonAmardeep Dhillon, J M MariadasonATF3 repression of BCL-XL determines apoptotic sensitivity to HDAC inhibitors across tumor types
History
Journal
Clinical Cancer ResearchVolume
23Issue
18Pagination
5573 - 5584Publisher
Association for Cancer ResearchLocation
Denville, N.J.Publisher DOI
ISSN
1078-0432eISSN
1557-3265Language
engPublication classification
C1 Refereed article in a scholarly journalUsage metrics
Categories
No categories selectedKeywords
Licence
Exports
RefWorks
BibTeX
Ref. manager
Endnote
DataCite
NLM
DC